Reliable Biopharmaceutical
Reliable Biopharmaceutical, headquartered in the United States, is a prominent player in the biopharmaceutical industry, specialising in the development and manufacturing of high-quality biologics and pharmaceuticals. Founded in 2004, the company has established itself as a trusted partner in the healthcare sector, with significant operations across North America and Europe. The firm is renowned for its innovative approach to biopharmaceutical production, offering a range of services including contract manufacturing, analytical testing, and regulatory support. Reliable Biopharmaceutical's commitment to quality and compliance has earned it a strong market position, with notable achievements in meeting stringent regulatory standards. By focusing on customer-centric solutions, the company continues to lead in the biopharmaceutical landscape, ensuring the delivery of safe and effective therapies.
DitchCarbon Score
How does Reliable Biopharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Reliable Biopharmaceutical's score of 27 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Reliable Biopharmaceutical's reported carbon emissions
Reliable Biopharmaceutical, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that Reliable Biopharmaceutical has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly committed to industry-standard climate pledges. As the biopharmaceutical industry increasingly focuses on sustainability and reducing carbon footprints, Reliable Biopharmaceutical's future commitments and actions will be crucial in aligning with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Reliable Biopharmaceutical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
